ES2721755T3 - Vacunas contra el virus de la tilapia del lago - Google Patents

Vacunas contra el virus de la tilapia del lago Download PDF

Info

Publication number
ES2721755T3
ES2721755T3 ES15749196T ES15749196T ES2721755T3 ES 2721755 T3 ES2721755 T3 ES 2721755T3 ES 15749196 T ES15749196 T ES 15749196T ES 15749196 T ES15749196 T ES 15749196T ES 2721755 T3 ES2721755 T3 ES 2721755T3
Authority
ES
Spain
Prior art keywords
lake
tilapia
tilv
vaccines against
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15749196T
Other languages
English (en)
Inventor
Eran Bacharach
Avi Eldar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
State Of Israel Mini Of Agriculture & Rural Development Kimron Veterinary Institute
Ramot at Tel Aviv University Ltd
Agricultural Research Organization of Israel Ministry of Agriculture
Original Assignee
State Of Israel Mini Of Agriculture & Rural Development Kimron Veterinary Institute
Ramot at Tel Aviv University Ltd
Agricultural Research Organization of Israel Ministry of Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by State Of Israel Mini Of Agriculture & Rural Development Kimron Veterinary Institute, Ramot at Tel Aviv University Ltd, Agricultural Research Organization of Israel Ministry of Agriculture filed Critical State Of Israel Mini Of Agriculture & Rural Development Kimron Veterinary Institute
Application granted granted Critical
Publication of ES2721755T3 publication Critical patent/ES2721755T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Una composición de vacuna que comprende una cepa atenuada de virus de la tilapia del lago (TiLV) para su uso en la protección de peces tilapia contra la infección por TiLV, donde dicho TiLV se deposita en la Collection Nationale de Cultures de Microorganismes (CNCM) del Institut Pasteur (Francia), con el Número de acceso de depósito CNCM 1-4817.
ES15749196T 2014-02-13 2015-02-11 Vacunas contra el virus de la tilapia del lago Active ES2721755T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL230970A IL230970A0 (en) 2014-02-13 2014-02-13 Tilapia virus vaccines
PCT/IL2015/050158 WO2015121858A1 (en) 2014-02-13 2015-02-11 Tilapia lake virus vaccines

Publications (1)

Publication Number Publication Date
ES2721755T3 true ES2721755T3 (es) 2019-08-05

Family

ID=51691267

Family Applications (2)

Application Number Title Priority Date Filing Date
ES15749196T Active ES2721755T3 (es) 2014-02-13 2015-02-11 Vacunas contra el virus de la tilapia del lago
ES18154927T Active ES2986415T3 (es) 2014-02-13 2015-02-11 Vacunas contra el virus de la tilapia del lago

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES18154927T Active ES2986415T3 (es) 2014-02-13 2015-02-11 Vacunas contra el virus de la tilapia del lago

Country Status (7)

Country Link
US (3) US9730998B2 (es)
EP (2) EP3104883B1 (es)
CN (2) CN110960674A (es)
ES (2) ES2721755T3 (es)
IL (2) IL230970A0 (es)
PT (1) PT3342422T (es)
WO (1) WO2015121858A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20210528A (es) 2014-12-15 2021-12-06 Univ Columbia VIRUS NUEVO DE TILAPIA Y USOS DEL MISMO(Divisional Exp: 2017-0322)
BR112018014042A2 (pt) * 2016-01-10 2019-02-12 Kovax Ltd. vírus do tipo orthomyxo da tilápia.
CN106834308A (zh) * 2017-01-19 2017-06-13 中山大学 罗非鱼源无乳链球菌重组cbp蛋白疫苗的制备方法及其应用
CN107974515B (zh) * 2017-11-27 2021-05-14 广州双螺旋基因技术有限公司 一种罗非鱼罗湖病毒的恒温快速检测试剂盒
CN112889712A (zh) * 2021-01-28 2021-06-04 海南昌江元道养殖有限公司 一种高品质金鲳鱼标准化健康养殖方法
NL2028806B1 (en) 2021-07-22 2022-06-03 Univ Northwest A&F Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
CA2459141A1 (en) 2001-08-27 2003-03-06 Advanced Bionutrition Corporation Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
AU2002233969A1 (en) 2001-12-07 2003-06-23 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
IL153775A0 (en) * 2003-01-01 2003-07-31 Yissum Res Dev Co Immunizing fish against viral infection
US8796436B2 (en) 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US7204993B2 (en) * 2004-03-18 2007-04-17 The United States Of America As Represented By The Secretary Of Agriculture Streptococcus agalactiae vaccine
CN100569285C (zh) * 2006-05-16 2009-12-16 福建省农业科学院生物技术研究所 免疫刺激复合物在制备鱼类免疫制剂中的应用
US20090149641A1 (en) 2007-03-07 2009-06-11 Nofima Akvaforsk-Fiskeriforskning As Fish disease protection
CL2008003262A1 (es) * 2007-11-02 2009-06-26 Intervet Int Bv Vacuna que comprende lactococcus garviae, pasteurella piscicida, vibrio anguillarum y nocardia seriolae; y uso de dichas bacterias para combatir infecciones de nocardia en peces.
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
CN101890159B (zh) * 2010-06-23 2012-07-25 广西壮族自治区水产研究所 罗非鱼二联链球菌灭活疫苗的制备方法
CN102847146B (zh) * 2011-09-15 2013-12-11 通威股份有限公司 一种预防罗非鱼链球菌病的疫苗
CN102716481A (zh) * 2011-12-15 2012-10-10 广西壮族自治区水产研究所 一种罗非鱼用口服疫苗免疫佐剂及其应用
RU2492557C1 (ru) * 2012-09-11 2013-09-10 Федеральное государственное бюджетное учреждение науки Институт общей и неорганической химии им. Н.С. Курнакова Российской академии наук (ИОНХ РАН) Композиционный катодный материал
CR20210528A (es) * 2014-12-15 2021-12-06 Univ Columbia VIRUS NUEVO DE TILAPIA Y USOS DEL MISMO(Divisional Exp: 2017-0322)

Also Published As

Publication number Publication date
EP3342422A1 (en) 2018-07-04
ES2986415T3 (es) 2024-11-11
EP3104883B1 (en) 2019-04-10
CN110960674A (zh) 2020-04-07
EP3104883A1 (en) 2016-12-21
US10537631B2 (en) 2020-01-21
CN106456737A (zh) 2017-02-22
CN106456737B (zh) 2019-12-03
US20180008692A1 (en) 2018-01-11
US20160354458A1 (en) 2016-12-08
IL230970A0 (en) 2014-09-30
US10071152B2 (en) 2018-09-11
IL247185B (en) 2019-06-30
PT3342422T (pt) 2024-09-09
US9730998B2 (en) 2017-08-15
WO2015121858A1 (en) 2015-08-20
US20190216914A1 (en) 2019-07-18
EP3104883A4 (en) 2017-08-23
EP3342422B1 (en) 2024-06-19
IL247185A0 (en) 2016-09-29

Similar Documents

Publication Publication Date Title
ES2721755T3 (es) Vacunas contra el virus de la tilapia del lago
CO2019000099A2 (es) Composiciones que comprenden cepas bacterianas
EP4450516A3 (en) A vaccine for use in the prophylaxis and/or treatment of a disease
MX2020005187A (es) Compuestos y composiciones farmaceuticas antivirales, asi como metodos de uso de los mismos.
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
CL2016001235A1 (es) Cepa bacteriana aislada del genero burkholderia y metabolitos plaguicidas derivados-formulaciones y usos (divisional solicitud 467-2014).
EP4691484A3 (en) Influenza mrna vaccines
MX342716B (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
CL2016002402A1 (es) Composiciones inmunológicas que contiene histophilus somni atenuado
BR112017000464A2 (pt) células gama delta t e uso das mesmas
EA201891124A2 (ru) Новые мукозные адъюванты и системы доставки
PE20181135A1 (es) Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
CL2016002442A1 (es) Rnasa para su uso en el tratamiento o la prevención de infecciones virales.
PH12019501569A1 (en) Universal influenza vaccine compositions
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
BR112018072372A2 (pt) combinações de vacina terapêutica contra o hpv
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
WO2016100615A3 (en) Methods and composition for neutralization of influenza
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo
WO2016081859A3 (en) Method and compositions for the prevention and treatment of a hiv infection
CL2015003616A1 (es) Cepa de piscirickettsia salmonis depositada bajo el numero de registro dms 27338; vacuna que la comprende; uso para prevenir infeccion por p. salmonis; y medio de cultivo para p. salmonis.
CL2017001008A1 (es) Uso de una composicion de vacuna de hpv para tratar cancer y lesion de la piel.
MX393033B (es) Virus vivo que tiene un banco de cepas atenuadas del virus del dengue, y una vacuna contra el dengue que contiene el mismo como antígenos.
GB2547835A (en) Protective material